ANGPT2 and breast carcinoma: In a preclinical mouse model of breast cancer, angiopoietin-2 (Ang2) neutralizing antibody treatment significantly improved the vascular structure, partly due to the recruitment of mature pericytes (Desmin+) and reduced hypoxia [23].